Safety and efficacy of γ-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction

Synapse

Volumn 55, Issue 2, 2005, Pages 122-125

  Brodie, Jonathan D ^a   Figueroa, Emilia ^b   Laska, Eugene M ^a,c   Dewey, Stephen L ^a,d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Clin Intg Tratam Contra Adicc   (Mexico)

^c NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^d BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

Addiction; Cocaine; Methamphetamine; Treatment; Vigabatrin

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; DIAMORPHINE; METHAMPHETAMINE; VIGABATRIN;

ABSTINENCE; APPETITE; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COCAINE DEPENDENCE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOSE TIME EFFECT RELATION; DRUG DEPENDENCE; DRUG EFFICACY; DRUG SAFETY; DRUG URINE LEVEL; FEMALE; HUMAN; MALE; OPEN STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; URINALYSIS; VISUAL ACUITY; VISUAL FIELD; VISUAL FIELD DEFECT; WEIGHT GAIN;

COCAINE-RELATED DISORDERS; ENZYME INHIBITORS; FEMALE; HUMANS; MALE; METHAMPHETAMINE; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME; VIGABATRIN;

EID: 10844262539     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.20097     Document Type: Article

References (26)

1. Ashby Jr CR, Rohatgi R, Ngosuwan J, Borda T, Gerasimov MR, Morgan AE, Kushner S, Brodie JD, Dewey SL. 1999. Implication of the GABA(B) receptor in gamma vinyl-GABA's inhibition of cocaine-induced increases in nucleus accumbens dopamine. Synapse 3:151-153.
2. Brodie JD, Figueroa E, Dewey SL. 2003. Treating cocaine addiction: from preclinical to clinical trial experience with gamma-vinyl GABA. Synapse 50:261-265.
3. Bruni J, Guberman A, Vachon L, Desforges C. 2000. Vigabatrin as add-on therapy for adult complex partial seizures: a double-blind, placebo-controlled multicentre study. Seizure-Eur J Epilepsy 9:224-232.
4. Carroll K, Rounsaville BJ, Gordon LT, Nich C, Jatlow P, Gawin F. 1994. One- year follow up of psychotherapy and pharmacotherapy for cocaine dependence: delayed emergence of psychotherapy effects. Arch Gen Psychiatry 51:989-997.
5. Dewey SL, Morgan AE, Ashby CR, Horan B, Kushner SA, Logan J, Volkow ND, Fowler JS, Gardner EL, Brodie JD. 1998. A Novel Strategy for the Treatment of Cocaine Addiction. Synapse 30:119-129.
6. Dewey SL, Brodie JD, Gerasimov M, Horan B, Gardner EL, Ashby Jr CR. 1999. A pharmacologie strategy for the treatment of nicotine addiction. Synapse 31:76-86.
7. Gardner EL, Schiffer WK, Horan BA, Highfield D, Dewey SL, Brodie JD, Ashby Jr CR. 2002. Gamma-vinyl GABA, an irreversible inhibitor of GABA transaminase, alters the acquisition and expression of cocaine-induced sensitization in male rats. Synapse 46:240-250.
8. Gerasimov MR, Ashby CR, Gardner EL, Mills MJ, Brodie JD, Dewey SL. 1999. Gamma-vinyl GABA inhibits methamphetamine, heroin, or ethanol-induced increases in nucleus accumbens dopamine. Synapse 34:11-19.
9. Gerasimov MR, Schiffer WK, Brodie JD, Lennon IC, Taylor SJ, Dewey SL. 2000. gamma-aminobutyric acid mimetic drugs differentially inhibit the dopaminergic response to cocaine. Eur J Pharmacol 395:129-135.
10. Gerasimov MR, Schiffer WK, Gardner EL, Marsteller DA, Lennon IC, Taylor SJ, Brodie JD, Ashby Jr CR, Dewey SL. 2001. GABAergic blockade of cocaine-associated cue-induced increases in nucleus accumbens dopamine. Eur J Pharmacol 414:205-209.
11. Izumi Y, Ishikawa M, Benz AM, Izumi M, Zorumski CF, Thio LL. 2004. Acute vigabatrin retinotoxicity in albino rats depends on light but not GABA. Epilepsia 5:1043-1048.
12. Kosten T, Gawin FH, Kosten TA, Morgan C, Rounsaville BJ, Schottenfeld R, Kleber HD. 1992. Six-month follow-up of short-term pharmacotherapy for cocaine dependence. Am J Addict 1:40-49.
13. Kushner SA, Dewey SL, Kornetsky C. 1997. Gamma-vinyl GABA attenuates cocaine-induced lowering of brain stimulation reward thresholds. Psychopharmacology (Berl) 133:383-388.
14. Kushner SA, Dewey SL, Kornetsky C. 1999. The irreversible gamma-Aminobutyric Acid (GABA) transaminase inhibitor gamma-vinyl-GABA blocks cocaine self-administration in rats. J Pharmacol Exp Ther 290:797-808.
15. Laska EM, Meisner M. 1992. Nonparametric estimation and testing in a cure model. Biometrics 48:1223-1234.
16. Lee DE, Schiffer WK, Dewey SL. 2004. Gamma-Vinyl GABA (vigabatrin) blocks the expression of toluene-induced conditioned place preference (CPP). Synapse 54:183-185.
17. Manuchehri K, Goodman S, Siviter L, Nightingale S. 2000. A controlled study of vigabatrin and visual abnormalities. Br J Ophthalmol 84:499-505.
18. Morgan AE, Dewey SL. 1998. Effects of pharmacologic increases in brain GABA levels on cocaine-induced changes in extracellular dopamine. Synapse 28:60-65.
19. Nicolson A, Leach JP, Chadwick DW, Smith DF. 2002. The legacy of vigabatrin in a regional epilepsy clinic. J Neurol Neurosurg Psychiatry 73:327-329.
20. Paul M, Dewey S, Gardner E, Brodie J, Ashby C. 2001. Gamma-vinyl GABA (GVG) blocks expression of the conditioned place preference response to heroin in rats. Synapse 41:219-220.
21. SAMSA (Substance Abuse and Mental Health Administration, Office of National Drug Control Policy). 2000. National Survey on Drug Abuse.
22. Schiffer WK, Gerasimov M, Hoffman L, Marsteller D, Ashby CR, Brodie JD, Dewey SL. 2001. Gamma vinyl-GABA differentially modulates NMDA antagonist-induced increases in mesocortical versus mesolimbic DA transmission. Neuropsychopharmacology 25:704-712.
23. Schiffer WK, Marsteller D, Dewey SL. 2003. Sub-chronic low dose gamma-vinyl GABA (vigabatrin) inhibits cocaine-induced increases in nucleus accumbens dopamine. Psychopharmacology (Berl) 168:339-343.
24. Schmitz B, Schmidt T, Jokiel B, Pfeiffer S, Tiel-Wilck K, Ruther K. 2002. Visual field constriction in epilepsy patients treated with vigabatrin and other antiepileptic drugs: a prospective study. J Neurol 249:469-475.
25. Stromberg MF, Mackler SA, Volpicelli JR, O'Brien CP, Dewey SL. 2001. The effect of gamma-vinyl-GABA on the consumption of concurrently available oral cocaine and ethanol in the rat. Pharmacol Biochem Behav 68:291-299.
26. Takada K, Yanagita T. 1997. Drug dependence study on vigabatrin in rhesus monkeys and rats. Arzneimittel-Forschung/Drug Res 47:1087-1092.